Schistosomiasis Mansoni Clinical Trial
Official title:
Evaluation of Applicability of Urine Based Schistosomiasis Test Strip in the Epidemiologic Mapping and Sampling of Schistosoma Mansoni Infection in Low Endemic Areas of Kenya
The purpose of this study is to evaluate the use of a urine test strip in diagnose
schistosoma mansoni in areas of Kenya where the rate of infections are low.
The hypothesis is that the urine strip test is a superior tool to the conventional
parasitological tools used to diagnose schistosomiasis mansoni infections in area where
there is low transmission
The study will compare the use of the urine test strip with the conventional method used and
with a "golden standard" methode, in an area of Kenya where the infection transmission is
low. Furthermore will the urine test strip be evaluatied in its ability to monitor the
intensity of infections in school children before and after they are been treated for the
infections.
A total of 1100 school children in the age between 10 and 18 years will be included in the
study. Children have to submitt a stool and a urine sample on three consecutive days.
Children who are found to be infected with the schistosomiasis parasite will be offered
treatment.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06055530 -
Evaluation of an AI-DP for STH Deworming Programs: a Study Protocol
|
||
Completed |
NCT02878564 -
Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology
|
Phase 4 | |
Completed |
NCT00403611 -
Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Brazil
|
Phase 4 | |
Active, not recruiting |
NCT05788003 -
Female Genital Schistosomiasis in Tanzania
|
N/A | |
Recruiting |
NCT05658614 -
Anti-Schistosomiasis Sm14-vaccine in Senegal
|
Phase 2 | |
Completed |
NCT01931826 -
Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or Surgery
|
N/A | |
Recruiting |
NCT03640377 -
Praziquantel in Children Under Age 4
|
Phase 2 | |
Completed |
NCT01529710 -
Safety and Efficacy of Mirazid for Schistosomiasis Treatment
|
Phase 3 | |
Completed |
NCT04269915 -
Single-sex Female Controlled Human Schistosomiasis Mansoni Infection
|
N/A |